Published in
Elsevier, European Journal of Cancer, (195), p. 113386, 2023
DOI: 10.1016/j.ejca.2023.113386
Links
Tools
Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)
Journal article published in 2023 by
Se Hyun Kim 
,
Seock-Ah Im,
Koung Jin Suh ,
Kyung-Hun Lee ,
Min Hwan Kim,
Joohyuk Sohn ,
Yeon Hee Park,
Ji-Yeon Kim,
Jae Ho Jeong,
Kyoung Eun Lee ,
In Sil Choi ,
Kyong Hwa Park ,
Hee-Jun Kim ,
Eun Kyung Cho,
So Yeon Park
and other authors.
,
Seock-Ah Im,
Koung Jin Suh ,
Kyung-Hun Lee ,
Min Hwan Kim,
Joohyuk Sohn ,
Yeon Hee Park,
Ji-Yeon Kim,
Jae Ho Jeong,
Kyoung Eun Lee ,
In Sil Choi ,
Kyong Hwa Park ,
Hee-Jun Kim ,
Eun Kyung Cho,
So Yeon Park
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 